Clinical Trials
55 trials18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
National Institutes of Health Clinical Center (CC)
TENS 2
Medical University of Gdansk
Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis
Peking University First Hospital
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
NYU Langone Health
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
Cedars-Sinai Medical Center
Theranostic Applications of Radionuclides in Prostate Cancer
Guilin Medical University, China
LUTACT
University of California, San Francisco
INSIGHT-PCa
Asan Medical Center
Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis
Peking University First Hospital
MUSIC-PRT
Dokuz Eylul University
REMRI
University of Eastern Finland
EBNK-ST-001
Essen Biotech
PSMA PET for Surveillance After Focal Therapy
University of Chicago
ADHERE
Royal Marsden NHS Foundation Trust
Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)
SMED Clinical Research
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
Johns Hopkins University
exo-PRECISE
Xijing Hospital
NMIBC
Xijing Hospital
FOCUS-PC
Albany Medical College
Spotlight
Blue Earth Diagnostics
PREPP
Odense University Hospital
HOPE
Institut Curie
URODX-FGFR3
Institut de Cancérologie de Lorraine
Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis
Peking University First Hospital
Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.
Blue Earth Diagnostics
Optimizing Prostate Biopsy Schemes in Men With Multiple mpMRI Visible Lesions
Peking University First Hospital
BIOPSTAGE
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
F-PSMA
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial
Peking University First Hospital
PRIME
University College, London
RPWPB
Anhui Provincial Hospital
CMNDPC
First Affiliated Hospital Xi'an Jiaotong University
Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle
Region Skane
ProBioM
Odense University Hospital
IRMAA
University Hospital, Clermont-Ferrand
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors
M.D. Anderson Cancer Center
CLETUR
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Medical Economics of Urinary PCA3 Test for Prostate Cancer Diagnosis
Hospices Civils de Lyon
OSPREY
Progenics Pharmaceuticals, Inc.
MULTIPROS
University of Dundee
CONDOR
Progenics Pharmaceuticals, Inc.
ProSa-I
University of Roma La Sapienza
New Biopsy Needle - Evaluation of Prostate Biopsy Quality
Region Skane
RITE-USA
Medical Enterprises Ltd.
Predicting Prostate Cancer in Elderly Men
Odense University Hospital
CaNCaP02
Cambridge University Hospitals NHS Foundation Trust
RCCSCAN
Region Skane
proSPECT-AS
Molecular Insight Pharmaceuticals, Inc.
PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer
NYU Langone Health
Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device
Focal Healthcare Inc.